International Journal of Social Science & Economic Research
Submit Paper

Title:
Comparative Analysis of TAVR and SAVR for Treatment of Aortic Valve Disease: Innovations and Implications

Authors:
Bao Le

|| ||

Bao Le
Lake Forest Academy Vietnam

MLA 8
Le, Bao. "Comparative Analysis of TAVR and SAVR for Treatment of Aortic Valve Disease: Innovations and Implications." Int. j. of Social Science and Economic Research, vol. 9, no. 12, Dec. 2024, pp. 6290-6301, doi.org/10.46609/IJSSER.2024.v09i12.042. Accessed Dec. 2024.
APA 6
Le, B. (2024, December). Comparative Analysis of TAVR and SAVR for Treatment of Aortic Valve Disease: Innovations and Implications. Int. j. of Social Science and Economic Research, 9(12), 6290-6301. Retrieved from https://doi.org/10.46609/IJSSER.2024.v09i12.042
Chicago
Le, Bao. "Comparative Analysis of TAVR and SAVR for Treatment of Aortic Valve Disease: Innovations and Implications." Int. j. of Social Science and Economic Research 9, no. 12 (December 2024), 6290-6301. Accessed December, 2024. https://doi.org/10.46609/IJSSER.2024.v09i12.042.

References

[1] . Freeman, R. V. & Otto, C. M. Spectrum of Calcific Aortic Valve Disease. Circulation 111, 3316–3326 (2005).
[2] . Foroutan, F. et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ i5065 (2016) doi:10.1136/bmj.i5065.
[3] . Lindroos, M., Kupari, M., Heikkilä, J. & Tilvis, R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220–1225 (1993).
[4] . Guerbaii, R.-A. et al. Asymptomatic aortic stenosis: An assessment of patients’ and of their general practitioners’ knowledge, after an indexed specialized assessment in community practice. PLOS ONE 12, e0178932 (2017).
[5] . Thoenes, M. et al. Patient screening for early detection of aortic stenosis (AS)—review of current practice and future perspectives. J. Thorac. Dis. 10, 5584 (2018).
[6] . Aortic Stenosis Overview. www.heart.org https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/heart-valve-problems-and-causes/problem-aortic-valve-stenosis.
[7] . Overview: Heart valve diseases. in InformedHealth.org [Internet] (Institute for Quality and Efficiency in Health Care (IQWiG), 2019).
[8] . Meredith Am, I. T. et al. Transcatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve System. J. Am. Coll. Cardiol. 64, 1339–1348 (2014).
[9] . Redaelli, A. & Cooper-White, J. Bioengineering of the heart. APL Bioeng. 4, 010402 (2020).
[10] . Hadji, F. et al. Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1. Circulation 134, 1848–1862 (2016).
[11] . Pathogenesis of Calcific Aortic Valve Disease | Arteriosclerosis, Thrombosis, and Vascular Biology. https://www.ahajournals.org/doi/full/10.1161/01.ATV.0000227513.13697.ac.
[12] . Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).
[13] . S, á M. P. B. O. et al. Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement. JACC Cardiovasc. Interv. 14, 211–220 (2021).
[14] . Komosa, A. et al. Transcatheter Aortic Valve Replacement Is Associated with Less Oxidative Stress and Faster Recovery of Antioxidant Capacity than Surgical Aortic Valve Replacement. J. Clin. Med. 8, 1364 (2019).
[15] . Smith, C. R. et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N. Engl. J. Med. 364, 2187–2198 (2011).
[16] . Nishimura, R. A. et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129, e521-643 (2014).
[17] . Vahanian, A. VALVE DISEASE: Balloon valvuloplasty. Heart 85, 223–228 (2001).
[18] . Phan, K., Zhou, J. J., Niranjan, N., Di Eusanio, M. & Yan, T. D. Minimally invasive reoperative aortic valve replacement: a systematic review and meta-analysis. Ann. Cardiothorac. Surg. 4, 15–25 (2015).
[19] . Lee, J. W., Lee, S. K., Choo, S. J., Song, H. & Song, M. G. Routine minimally invasive aortic valve procedures. Cardiovasc. Surg. Lond. Engl. 8, 484–490 (2000).
[20] . Christiansen, S. et al. Minimally-invasive versus conventional aortic valve replacement--perioperative course and mid-term results. Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg. 16, 647–652 (1999).
[21] . Goel, K. & Holmes, D. R. J. Transcatheter Aortic Valve Replacement: OPTIMIZING OUTCOMES FOR HEALTHY RECOVERY. J. Cardiopulm. Rehabil. Prev. 38, 1 (2018).
[22] . Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement | Valvular Heart Disease | JAMA | JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/2190986.
[23] . Tarro Genta, F. et al. Cardiac rehabilitation after transcatheter aortic valve implantation compared to patients after valve replacement. J. Cardiovasc. Med. 18, 114 (2017).
[24] . Shah, K. K. et al. Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study. Heart Lung Circ. 30, 1918–1928 (2021).
[25] . Muneretto, C. et al. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in “real-world” patients with aortic stenosis and intermediate- to high-risk profile. J. Thorac. Cardiovasc. Surg. 150, 1570–1579 (2015).
[26] . Mendelson, K. & Schoen, F. J. Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges. Ann. Biomed. Eng. 34, 1799–1819 (2006).
[27] . Brown, J. M. et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 137, 82–90 (2009).
[28] . Al-Adhami, A. & Al-Attar, N. Recent advances in aortic valve replacement for aortic stenosis. F1000Research 5, F1000 Faculty Rev (2016).
[29] . Kamo, Y. et al. A study on the prevalence, distribution and related factors of heart valve calcification using coronary CT angiography. IJC Heart Vasc. 29, 100571 (2020).
[30] . Iung, B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).

ABSTRACT:
Aortic valve disease (AVD) encompasses significant pathologies such as aortic valve stenosis (AVS) and regurgitation, primarily affecting the elderly population. This review examines four prevalent treatments for AVD: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR), Sutureless Aortic Valve Replacement (SuAVR), and Balloon Aortic Valvuloplasty (BAV). We explore the epidemiology, etiology, and global impact of AVD, highlighting the economic burden associated with untreated cases. A comparative analysis of SAVR and TAVR reveals differences in risk profiles, cost-effectiveness, and survival rates. While SAVR offers superior long-term outcomes, TAVR provides a less invasive option with favorable short-term results, particularly for high-risk patients. Technological advancements continue to pave the way for better treatments of AVD.

IJSSER is Member of